LAWRENCE C BEST Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LAWRENCE C BEST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LAWRENCE C BEST. LAWRENCE C BEST is Director in HAEMONETICS CORP ($HAE) and Director in MYRIAD GENETICS INC ($MYGN).
Latest Insider Trading Transactions of LAWRENCE C BEST
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 06 2019 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 11,687 | 0 | 60,790 | 49.1 K to 60.8 K (+23.80 %) |
Nov 30 2018 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 9,360 | 0 | 49,103 | 39.7 K to 49.1 K (+23.55 %) |
Nov 30 2017 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 7,219 | 0 | 39,743 | 32.5 K to 39.7 K (+22.20 %) |
Dec 01 2016 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 15,024 | 0 | 32,524 | 17.5 K to 32.5 K (+85.85 %) |
Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 7,500 | 0 | 17,500 | 10 K to 17.5 K (+75.00 %) |
Jun 13 2014 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | M | 24.96 | 5,000 | 124,800 | 0 | |
Jun 13 2014 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | M | 24.96 | 4,184 | 104,433 | 5,000 | |
Jun 13 2014 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 33.91 | 5,000 | 169,559 | 10,001 | 15 K to 10 K (-33.33 %) |
Jun 13 2014 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | M | 24.96 | 5,000 | 124,800 | 15,001 | 10 K to 15 K (+50.00 %) |
Jun 13 2014 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 33.91 | 4,184 | 141,882 | 10,001 | 14.2 K to 10 K (-29.50 %) |
Jun 13 2014 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | M | 24.96 | 4,184 | 104,433 | 14,185 | 10 K to 14.2 K (+41.84 %) |
Jul 26 2013 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 45.45 | 6,573 | 298,743 | 6,573 | |
Jul 26 2013 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.00 | 1,649 | 0 | 10,001 | 8.4 K to 10 K (+19.74 %) |
May 07 2013 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | M | 26.38 | 12,000 | 316,560 | 0 | |
May 07 2013 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 38.32 | 12,000 | 459,830 | 8,352 | 20.4 K to 8.4 K (-58.96 %) |
May 07 2013 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | M | 26.38 | 12,000 | 316,560 | 20,352 | 8.4 K to 20.4 K (+143.68 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 1,031 | 10 | 4,176 | 3.1 K to 4.2 K (+32.78 %) |
Jul 22 2011 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 68.81 | 3,559 | 244,895 | 3,559 | |
Jul 22 2011 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 944 | 9 | 3,145 | 2.2 K to 3.1 K (+42.89 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 1,193 | 12 | 2,201 | 1 K to 2.2 K (+118.35 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 54.48 | 4,290 | 233,719 | 4,290 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 52.76 | 6,000 | 316,560 | 6,000 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 49.92 | 4,592 | 229,233 | 4,592 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 44.74 | 6,000 | 268,440 | 6,000 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 26.11 | 6,000 | 156,630 | 6,000 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 20.47 | 20,000 | 409,300 | 20,000 | |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 54.48 | 1,193 | 64,995 | 2,201 | 1 K to 2.2 K (+118.35 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.42 | 50,000 | 2,670,850 | 1,008 | 51 K to 1 K (-98.02 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.63 | 25,000 | 1,340,790 | 51,008 | 76 K to 51 K (-32.89 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.51 | 25,000 | 1,337,680 | 76,008 | 101 K to 76 K (-24.75 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 367 | 4 | 101,008 | 100.6 K to 101 K (+0.36 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 354 | 4 | 100,641 | 100.3 K to 100.6 K (+0.35 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 287 | 3 | 100,287 | 100 K to 100.3 K (+0.29 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.87 | 600 | 28,122 | 100,000 | 99.4 K to 100 K (+0.60 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.99 | 3,000 | 140,970 | 99,400 | 96.4 K to 99.4 K (+3.11 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.67 | 200 | 9,334 | 96,400 | 96.2 K to 96.4 K (+0.21 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.75 | 600 | 28,050 | 96,200 | 95.6 K to 96.2 K (+0.63 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.55 | 200 | 9,310 | 95,600 | 95.4 K to 95.6 K (+0.21 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.35 | 2,300 | 106,605 | 95,400 | 93.1 K to 95.4 K (+2.47 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.25 | 6,800 | 314,500 | 93,100 | 86.3 K to 93.1 K (+7.88 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.64 | 5,100 | 237,864 | 86,300 | 81.2 K to 86.3 K (+6.28 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.62 | 500 | 23,310 | 81,200 | 80.7 K to 81.2 K (+0.62 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.41 | 500 | 23,205 | 80,700 | 80.2 K to 80.7 K (+0.62 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.31 | 3,900 | 180,609 | 80,200 | 76.3 K to 80.2 K (+5.11 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 47.00 | 20,500 | 963,500 | 76,300 | 55.8 K to 76.3 K (+36.74 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.70 | 13,500 | 630,450 | 55,800 | 42.3 K to 55.8 K (+31.91 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.60 | 1,400 | 65,240 | 42,300 | 40.9 K to 42.3 K (+3.42 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.50 | 18,100 | 841,650 | 40,900 | 22.8 K to 40.9 K (+79.39 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.30 | 4,600 | 212,980 | 22,800 | 18.2 K to 22.8 K (+25.27 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.00 | 11,500 | 529,000 | 18,200 | 6.7 K to 18.2 K (+171.64 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.89 | 200 | 9,378 | 6,700 | 6.5 K to 6.7 K (+3.08 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.49 | 400 | 18,596 | 6,500 | 6.1 K to 6.5 K (+6.56 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.39 | 200 | 9,278 | 6,100 | 5.9 K to 6.1 K (+3.39 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 45.99 | 900 | 41,391 | 5,900 | 5 K to 5.9 K (+18.00 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.88 | 300 | 14,064 | 5,000 | 4.7 K to 5 K (+6.38 %) |
Aug 02 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.48 | 4,700 | 218,456 | 4,700 | 0 to 4.7 K |
Feb 19 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.42 | 50,000 | 2,670,850 | 1,008 | 51 K to 1 K (-98.02 %) |
Feb 18 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.63 | 25,000 | 1,340,790 | 51,008 | 76 K to 51 K (-32.89 %) |
Feb 18 2010 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Sell | S | 53.51 | 25,000 | 1,337,680 | 76,008 | 101 K to 76 K (-24.75 %) |
Aug 03 2009 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 367 | 4 | 101,008 | 100.6 K to 101 K (+0.36 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 354 | 4 | 100,641 | 100.3 K to 100.6 K (+0.35 %) |
Aug 03 2007 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 49.92 | 4,592 | 229,233 | 4,592 | |
Aug 03 2007 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 287 | 3 | 100,287 | 100 K to 100.3 K (+0.29 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.87 | 600 | 28,122 | 100,000 | 99.4 K to 100 K (+0.60 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.99 | 3,000 | 140,970 | 99,400 | 96.4 K to 99.4 K (+3.11 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.67 | 200 | 9,334 | 96,400 | 96.2 K to 96.4 K (+0.21 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.75 | 600 | 28,050 | 96,200 | 95.6 K to 96.2 K (+0.63 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.55 | 200 | 9,310 | 95,600 | 95.4 K to 95.6 K (+0.21 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.35 | 2,300 | 106,605 | 95,400 | 93.1 K to 95.4 K (+2.47 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.25 | 6,800 | 314,500 | 93,100 | 86.3 K to 93.1 K (+7.88 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.64 | 5,100 | 237,864 | 86,300 | 81.2 K to 86.3 K (+6.28 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.62 | 500 | 23,310 | 81,200 | 80.7 K to 81.2 K (+0.62 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.41 | 500 | 23,205 | 80,700 | 80.2 K to 80.7 K (+0.62 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.31 | 3,900 | 180,609 | 80,200 | 76.3 K to 80.2 K (+5.11 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 47.00 | 20,500 | 963,500 | 76,300 | 55.8 K to 76.3 K (+36.74 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.70 | 13,500 | 630,450 | 55,800 | 42.3 K to 55.8 K (+31.91 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.60 | 1,400 | 65,240 | 42,300 | 40.9 K to 42.3 K (+3.42 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.50 | 18,100 | 841,650 | 40,900 | 22.8 K to 40.9 K (+79.39 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.30 | 4,600 | 212,980 | 22,800 | 18.2 K to 22.8 K (+25.27 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.00 | 11,500 | 529,000 | 18,200 | 6.7 K to 18.2 K (+171.64 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.89 | 200 | 9,378 | 6,700 | 6.5 K to 6.7 K (+3.08 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.49 | 400 | 18,596 | 6,500 | 6.1 K to 6.5 K (+6.56 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.39 | 200 | 9,278 | 6,100 | 5.9 K to 6.1 K (+3.39 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 45.99 | 900 | 41,391 | 5,900 | 5 K to 5.9 K (+18.00 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.88 | 300 | 14,064 | 5,000 | 4.7 K to 5 K (+6.38 %) |
Jun 19 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Buy | P | 46.48 | 4,700 | 218,456 | 4,700 | 0 to 4.7 K |
May 09 2006 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 52.76 | 6,000 | 316,560 | 6,000 | |
Sep 06 2005 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 44.74 | 6,000 | 268,440 | 6,000 | |
May 07 2004 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 26.11 | 6,000 | 156,630 | 6,000 | |
Aug 26 2003 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 20.47 | 20,000 | 409,300 | 20,000 |
Page: 1